Risk-benefit ratio or risk-benefit nonsense?

被引：3
|
作者：
Ernst, E
Resch, KL
机构：
[1] Postgraduate Medical School, University of Exeter, Exeter
[2] Complementary Medicine, University of Exeter, Postgraduate Medical School, Exeter EX2 4NT
来源：
JOURNAL OF CLINICAL EPIDEMIOLOGY | 1996年 / 49卷 / 10期
关键词：
D O I：
10.1016/0895-4356(96)00187-4
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1203 / 1204
页数：2
相关论文
共 50 条
  • [11] RISK-BENEFIT DETERMINATION
    ROWE, WD
    [J]. AMERICAN INDUSTRIAL HYGIENE ASSOCIATION JOURNAL, 1979, 40 (12): : 1200 - 1206
  • [12] ANALYZING RISK-BENEFIT
    不详
    [J]. CHEMISTRY IN BRITAIN, 1995, 31 (05) : 366 - 366
  • [13] Risk-benefit of dronedarone
    不详
    [J]. EJHP PRACTICE, 2011, 17 (01): : 15 - 15
  • [14] Risk-benefit assessments
    V. Yuvaraj
    B. Krishnan
    V. Murthy
    S. Prasad
    [J]. British Dental Journal, 2011, 210 : 151 - 151
  • [15] RISK-BENEFIT ANALYSIS
    ZENCEY, M
    [J]. ATLANTIC, 1979, 243 (04): : 37 - 37
  • [16] Risk-Benefit Relationships
    DeMaria, Anthony N.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (03) : 233 - 234
  • [17] Risk-benefit and cost-benefit ratio in headache treatment
    Pini L.A.
    Cainazzo M.M.
    Brovia D.
    [J]. The Journal of Headache and Pain, 2005, 6 (4) : 315 - 318
  • [18] RISK-BENEFIT ASSESSMENTS
    Yuvaraj, V.
    Krishnan, B.
    Murthy, V.
    Prasad, S.
    [J]. BRITISH DENTAL JOURNAL, 2011, 210 (04) : 151 - 151
  • [19] Evolution of risk-benefit ratio of antidepressant drugs
    Corruble, E
    Guelfi, JD
    [J]. THERAPIE, 1995, 50 (06): : 515 - 521
  • [20] Androgenic alopecia; the risk-benefit ratio of Finasteride
    Rowland, David L.
    Motofei, Ion G.
    Paunica, Ioana
    Banu, Petrisor
    Nistor, Mihaela F.
    Paunica, Stana
    Constantin, Vlad D.
    [J]. JOURNAL OF MIND AND MEDICAL SCIENCES, 2018, 5 (01): : 1 - 6
12345